EUVIMEDEUVIMED entdecken
Crossref

Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice

Mays T Ali, Mark Johnson, Timothy Irwin, Sonia Henry, Lissa Sugeng, Sarita Kansal, Thomas G Allison, Merri L Bremer, Victoria R Jones, Michael D Martineau, Connie Wong, Gregory Marecki und 11 weitere

Journal of the American Society of Echocardiography · 2024-03 · 37 (3) · 276-284.e3

DOI: 10.1016/j.echo.2023.10.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Society of Echocardiography, 2024-03. Verfasst von Mays T Ali und 22 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Ultrasound, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Drug-Related Side Effects and Adverse Reactions, Fluorocarbons. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesDrug-Related Side Effects and Adverse ReactionsFluorocarbonsHumansRetrospective StudiesProspective StudiesIncidenceEchocardiographyHeadacheBack Pain

Stichwörter der Autor:innen

Adverse drug reactionEchocardiographyImagingUltrasound enhancement agent

Substanzen

perflutrenCOVID-19 VaccinesFluorocarbons

Autor:innen und Institutionen

  • Division of Cardiovascular Ultrasound, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
  • University of South Dakota, Yankton Medical Clinic, Yankton, South Dakota.
  • Department of Cardiology, Northwell Health, Manhasset, New York.
  • WellStar Center for Cardiovascular Medicine, WellStar Health System, Atlanta, Georgia.
  • Division of Cardiovascular Ultrasound, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota; Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic, Rochester,…
  • Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota.

Zitieren

APA

Ali, M. T., Johnson, M., Irwin, T., Henry, S., Sugeng, L., Kansal, S., Allison, T. G., Bremer, M. L., Jones, V. R., Martineau, M. D., Wong, C., Marecki, G., Stebbins, J., Michelena, H. I., McCully, R. B., Svatikova, A., Padang, R., Scott, C. G., Kanuga, M. J., …, & Thaden, J. J. (2024). Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice. Journal of the American Society of Echocardiography, 37(3), 276-284.e3. https://doi.org/10.1016/j.echo.2023.10.010

Vancouver

Ali MT, Johnson M, Irwin T, Henry S, Sugeng L, Kansal S, et al. Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice. Journal of the American Society of Echocardiography. 2024;37(3):276-284.e3. doi:10.1016/j.echo.2023.10.010

BibTeX
@article{Ali2024,
  author = {Ali, Mays T and Johnson, Mark and Irwin, Timothy and Henry, Sonia and Sugeng, Lissa and Kansal, Sarita and Allison, Thomas G and Bremer, Merri L and Jones, Victoria R and Martineau, Michael D and Wong, Connie and Marecki, Gregory and Stebbins, Julie and Michelena, Hector I and McCully, Robert B and Svatikova, Anna and Padang, Ratnasari and Scott, Christopher G and Kanuga, Mansi J and Arsanjani, Reza and Pellikka, Patricia A and Kane, Garvan C and Thaden, Jeremy J},
  title = {Incidence of Severe Adverse Drug Reactions to Ultrasound Enhancement Agents in a Contemporary Echocardiography Practice},
  journal = {Journal of the American Society of Echocardiography},
  year = {2024},
  volume = {37},
  number = {3},
  pages = {276--284.e3},
  doi = {10.1016/j.echo.2023.10.010}
}
Kostenlos starten →